News

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
The first head-to-head trial shows Mounjaro helps people lose more weight than its rival Wegovy as scientists confirm why it ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.
It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: erm71@who.eop.gov. When the Intercept first published Musk’s email address, on March 6, journalist ...
Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster ...